Key result
Pulmonary hypertension in pregnancy carries high maternal morbidity and mortality requiring specialized multidisciplinary care.
Why the study?
Pulmonary hypertension is prevalent among women of reproductive age, is linked with poor prognosis during pregnancy, and pregnancy complicates its management.
This review highlights the critical need for a multidisciplinary approach and specific pharmacological considerations to manage pregnant women with pulmonary hypertension and mitigate maternal mortality.
Answers are grounded in this paper and cite their sources.
Supports multidisciplinary management of pulmonary hypertension in pregnancy; leaves open optimal non-teratogenic therapy selection pending prospective data.
Pulmonary hypertension (PH) is a heterogeneous disease characterized by an elevated mean pulmonary artery pressure of 20 mm Hg or above. PH is a prevalent condition among women of reproductive age and is linked with poor prognosis during pregnancy. Pregnancy is a stressful event and complicates the management and prognosis in patients with PH. In this review, we discuss the pathogenesis, clinical presentation as well as therapeutic options for PH during pregnancy. We also highlight knowledge gaps to guide future research.
No takes yet. Share an insight, caveat, or question.
Afify et al. (2022) conducted a review in Pulmonary hypertension in pregnancy. Pregnancy with pulmonary hypertension was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: